1000699-00-2Relevant articles and documents
SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS
-
Paragraph 00526-00527; 00530-00531, (2021/11/06)
Provided herein are compounds, pharmaceutical compositions and methods for treating a SARS-CoV-2 infection.
THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE
-
Page/Page column 209, (2012/02/02)
Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1 comprising administering to a subject in need thereof a compound described here.